Analyst Research

Report Title Price
Deinove SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Wright Investors Service Comprehensive Report for Deinove SA
Provider: Wright Reports
$368.00
Buy
DEINOVE - COMMERCIAL FOCUS
Provider: Edison Investment Research
$10.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Deinove SA Creates Subsidiary for its Antibiotics Program


Thursday, 21 Mar 2013 12:36pm EDT 

Deinove SA announced that it has established a dedicated subsidiary, DEINOBIOTICS, to accelerate the development of its antibiotics program. The Company owns 49% of the new entity and holds the right to buy back the outstanding shares. 

Latest Developments for Deinove SA

Latest Key Developments in Renewable

Company Quote

Deinove SA
(ALDEI.PA)
9.84
-0.06 -0.61%
11:35am EDT